A Phase I, The Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002

Conditions: Chronic Hepatitis b Interventions: Biological: YS-HBV-002 Sponsors: Yisheng Biopharma (Singapore) Pte. Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials